CrushSCI.com
58.7Average days
48Median days
1Fastest days
331Longest days
1822025 publications

Paper Review Records

All Paper Review Records

29 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

25 days

Chronic Lymphocytic Leukaemia as a Disease of Time: A Four‐Clock Framework for Therapeutic Stewardship

Authors
Fortunato Morabito; Enrica Antonia Martino; Ernesto Vigna; Massimo GentileShow moreShow less
Affiliations
1. Dafne Srl Reggio Calabria Italy; 2. Hematology Unit, Department of Onco‐Hematology AO of Cosenza Cosenza Italy; 3. Department of Pharmacy, Health and Nutritional Science University of Calabria Rende ItalyShow moreShow less
Source PDF DOI Publisher page
35 days

Efficacy, Safety, and Durability of Sutimlimab in Cold Agglutinin Disease: A Systematic Review and Meta‐Analysis

Authors
Jamiel Reyes; Alexander ReyesShow moreShow less
Affiliations
1. Department of Internal Medicine Universidad de Ciencias Médicas de Holguín Holguín Cuba; 2. Department of Software Engineering Universidad de Holguín Holguín CubaShow moreShow less
Source PDF DOI Publisher page
66 days

Comparative Prognostic Value of Mayo 2012 and European‐Modified Mayo 2004 Staging Systems in Systemic AL Amyloidosis With Discordant Risk Classification

Authors
Miran Han; Jun Ho Yi; Sang Eun Yoon; Seokjin Kim; Darae Kim; Jin‐Oh Choi; Jung Eun Lee; Jung‐Sun Kim; Ju‐Hong Min; Byoung Joon Kim; Kihyun KimShow moreShow less
Affiliations
1. Division of Hematology–Oncology, Department of Medicine Samsung Medical Center, Sungkyunkwan University School of Medicine Seoul Korea; 2. Division of Hematology–Oncology, Department of Medicine Jeonbuk National University Medical School and Hospital Jeonju South Korea; 3. Division of Cardiology, Department of Medicine Samsung Medical Center, Sungkyunkwan University School of Medicine Seoul Korea; 4. Division of Nephrology, Department of Medicine Samsung Medical Center, Sungkyunkwan University School of Medicine Seoul Korea; 5. Department of Pathology and Translational Genomics Samsung Medical Center, Sungkyunkwan University School of Medicine Seoul Korea; 6. Department of Neurology Samsung Medical Center, Sungkyunkwan University School of Medicine Seoul KoreaShow moreShow less
Source PDF DOI Publisher page
28 days

Optimizing Frontline Targeted Therapies in Chronic Lymphocytic Leukemia: An Italian Inter‐Regional Delphi Consensus on Patient Risk Stratification, Cardiovascular Safety, and Endpoint Interpretation

Authors
Stefano Molica; Giacomo Loseto; Elsa Pennese; Francesco Aji; Angelo Fama; Annamaria Giordano; Giulio Giordano; Francesca Immacolata Merchionne; Rosanna Maria Miccolis; Gaetano Palumbo; Pamela Pinto; Sara Plebani; Stefania Scardino; Luana Schiattone; Antonio Giovanni Solimando; Maria Rosaria Specchia; Lorenzo Tonialini; Vincenzo Fraticelli; Potito Rosario Scalzulli; Daniela D'Angela; Stefano Oliva; Alessandro MaggiShow moreShow less
Affiliations
1. York‐Hull Medical School Hull UK; 2. UOC Ematologia, IRCCS Istituto Tumori “Giovanni Paolo II” Bari Italy; 3. UOC Ematologia Presidio Ospedaliero Pescara Pescara Italy; 4. UO Ematologia, Ospedale “Cardinale G. Panico” Tricase Italy; 5. UO Ematologia, Ospedale “Giuseppe Mazzini” Teramo Italy; 6. UO Ematologia, Azienda Ospedaliero Universitaria Consorziale Policlinico di Bari Bari Italy; 7. UO Ematologia, Ospedale “Antonio Cardarelli” Campobasso Italy; 8. UO Ematologia, Ospedale “A. Perrino” Brindisi Italy; 9. UO Ematologia, Ospedale “Mons. R. Dimiccoli” Barletta Italy; 10. UO Ematologia, Azienda Ospedaliero Universitaria Policlinico di Foggia Foggia Italy; 11. UO Ematologia, Ospedale “F. Miulli” Acquaviva delle Fonti Italy; 12. UO Ematologia, Presidio Ospedaliero “S. Salvatore” L'Aquila Italy; 13. UO Ematologia, Ospedale “Vito Fazzi” Lecce Italy; 14. UO Ematologia, Ospedale “Santo Spirito” Pescara Italy; 15. UO Medicina Interna, Azienda Ospedaliero Universitaria Consorziale Policlinico di Bari Bari Italy; 16. UO Ematologia, Ospedale “SS. Annunziata – Moscati” Taranto Italy; 17. UOC Ematologia, Policlinico “Gemelli” Molise Campobasso Italy; 18. UOC Ematologia, IRCCS “Casa Sollievo Della Sofferenza” San Giovanni Rotondo Italy; 19. Università Roma Tor Vergata Roma Italy; 20. UOSD Cardiologia, IRCCS Istituto Tumori “Giovanni Paolo II” Bari ItalyShow moreShow less
Source PDF DOI Publisher page
48 days

Patient‐Reported Symptom Burden and Objective Responses After Belumosudil in Heavily Pretreated Chronic GvHD

Authors
Sergio Rodriguez‐Rodriguez; Jennifer White; Kylie Lepic; Nihar Desai; Brittany Salter; Mohamed Elemary; Eshrak Al‐Shaibani; Tommy Alfaro‐Moya; Arjun D. Law; Igor Novitzky‐Basso; Ivan Pasic; Auro Viswabandya; Fotios V. Michelis; Rajat Kumar; Jonas Mattsson; Dennis D. H. KimShow moreShow less
Affiliations
1. University Health Network Princess Margaret Cancer Centre Toronto Ontario Canada; 2. University of Toronto Toronto Ontario Canada; 3. British Columbia Cancer Agency Vancouver General Hospital Vancouver British Columbia Canada; 4. University of British Columbia Vancouver British Columbia Canada; 5. Hamilton Health Sciences Juravinski Cancer Centre Hamilton Ontario Canada; 6. McMaster University Hamilton Ontario Canada; 7. Saskatchewan Cancer Agency Saskatoon Cancer Centre Saskatoon Saskatchewan Canada; 8. University of Saskatchewan Saskatoon Saskatchewan CanadaShow moreShow less
Source PDF DOI Publisher page
61 days

Efficacy and Safety of Doxorubicin–Etoposide–Methylprednisolone ( DEP )‐Based Regimens in Haemophagocytic Lymphohistiocytosis: A Systematic Review and Meta‐Analysis

Authors
Mostafa Rafea; Reem Hassan; Ahmed FayedShow moreShow less
Affiliations
1. London Northwest Healthcare NHS Trust Harrow UK; 2. London School of Hygiene and Tropical Medicine London UK; 3. Kasr Al‐Ainy School of Medicine, University of Cairo Cairo EgyptShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does EUROPEAN JOURNAL OF HAEMATOLOGY take to review a manuscript?

As of 2026-11-17, CrushSCI has 29 complete review records for EUROPEAN JOURNAL OF HAEMATOLOGY. The fastest paper went from submission to acceptance in 1 days (Current Challenges in Pediatric Hematology and Oncology: An Integrated Multidisciplinary Perspective, received 2026-05-19, accepted 2026-05-20); the slowest took 331 days. The average is 58.7 days and the median is 48 days. The fastest record has an unusually short interval; please check the original source.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.